-K Enjyoji Researcher Activity Profile

Research Author Detailed Information 

K Enjyoji Publication Rate By Year

K Enjyoji has published 1 paper(s) in 1988, 1 paper(s) in 1991, 2 paper(s) in 1992, 1 paper(s) in 1994, 1 paper(s) in 1996, 2 paper(s) in 1997, 1 paper(s) in 1999, 7 paper(s) in 2007, 4 paper(s) in 2008, for a total of 20 research publications in total.

K K Enjyoji Author Information

LAST NAME: enjyoji

FIRST NAME: K

INITIALS: k

AFFILIATION:

Papers

K Enjyoji's Publication Record

1. Characterization of serine proteinases isolated from rat submaxillary gland: with special reference to the degradation of rat kininogens by these enzymes. Year Published: 1988
Department of Biology, Faculty of Science, Kyushu University, Fukuoka.
2. Characterization of rat factors X and Xa: demonstration of factor Xa in rat plasma. Year Published: 1991
National Cardiovascular Center Research Institute, Osaka University.
3. Purification and characterization of two isoforms of T-kininogens from rat liver microsomes. Year Published: 1992
National Cardiovascular Center Research Institute, Osaka.
4. cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI). Year Published: 1992
National Cardiovascular Center Research Institute, Osaka.
5. Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI. Year Published: 1994
Chemo-Sero-Therapeutic Research Institute, Kumamoto.
6. An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma. Year Published: 1996
National Cardiovascular Center Research Institute, Osaka.
7. Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin. Year Published: 1997
Taiho Pharmaceutical Co., Ltd., Kawauchi-cho, Tokushima.
8. Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78. Year Published: 1997
Department of Biology, Graduate School of Science, Osaka University.
9. Monkey hepatocytes efficiently express tissue factor pathway inhibitor (TFPI), in contrast with human and rat hepatocytes. Year Published: 1999
National Cardiovascular Center Research Institute, Suita, Osaka, 565-8565, Japan.
10. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Year Published: 2007
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
11. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Year Published: 2007
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 02215, USA.
12. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Year Published: 2007
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 02215, USA.
13. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Year Published: 2008
Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
14. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Year Published: 2008
Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
15. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Year Published: 2008
Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
16. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Year Published: 2007
Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
17. Tubuloglomerular feedback and renin secretion in NTPDase1/CD39-deficient mice. Year Published: 2008
National Institute of Digestive and Diabetes and Kidney Diseases, National Institute of Health, 10 Center Drive-MSC 1370, Bethesda, MD 20892. jurgens@intra.niddk.nih.gov).
18. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Year Published: 2007
19. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. Year Published: 2007
Department of Medicine, Harvard Medical School, Transplantation Research Center, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
20. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. Year Published: 2007
Department of Medicine, Harvard Medical School, Transplantation Research Center, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.